Characteristics of ZZ-AATD and COPD patients employed in figures 3 and 4
| ZZ-AATD | COPD | |
| Number of subjects | 56 (n=51 plasma donors, n=5 BAL/IS donors) | 15 (n=10 plasma donors, n=5 BAL/IS donors) |
| Age, years (mean±SD) | 50.29±14.4 | 70.86±6.71 |
| Gender (male/female) | 31/25 | 8/7 |
| BMI | 26.78±5.2 | 31.01±4.28 |
| FEV1 (% predicted) | 77.2±33.6 | 57.3±23.32 |
| FVC (% predicted) | 105.7±23.9 | 87±5.29 |
| FEV1/FVC (% predicted) | 58.7±20.66 | 50±16.94 |
| DLCO (% predicted) | 65.56±24.9 | 36±10.86 |
AATD, alpha-1 antitrypsin deficiency; BAL, bronchoalveolar lavage; BMI, body mass index; COPD, chronic obstructive pulmonary disease; DLCO, Diffusion capacity for carbon monoxide; FEV1, Forced expiratory volume in one second; FVC, Forced vital capacity; IS, induced sputum.